Listing 1 - 10 of 15 | << page >> |
Sort by
|
Choose an application
Mouth --- Cancer --- Etiology --- Congresses --- Chemoprevention --- Throat --- Mouth - Cancer - Etiology - Congresses. --- Mouth - Cancer - Chemoprevention - Congresses. --- Throat - Cancer - Etiology - Congresses. --- Throat - Cancer - Chemoprevention - Congresses. --- Lung Neoplasms. --- Lung Neoplasms --- Head and neck neoplasms
Choose an application
Cancer --- Environmental Exposure. --- Neoplasms --- Environmental aspects. --- Epidemiology. --- Etiology. --- epidemiology. --- Etiology --- Epidemiology --- Environmental aspects --- Cancer - Etiology. --- Cancer - Epidemiology. --- Cancer - Environmental aspects.
Choose an application
Prostate cancer is a life-altering diagnosis, not just for patients, but for their loved ones as well. Once, prostate cancer was most frequently diagnosed in men in their 60s and 70s; with increasing use of imaging modalities and PSA testing, the incidence is on the rise, and we are now seeing men in their 40s with the disease. This poses a challenge for clinical management depending on the stage of the disease—from watchful waiting or active surveillance to aggressive treatment with the risk of therapeutic nihilism. Despite being one of the most common cancers in Western men, its natural history, prognosis, and treatment are poorly understood. This book brings together a select faculty of experts to present a comprehensive view of the current state and future perspectives of prostate cancer. There are ten chapters in the book—the first four cover our present knowledge and understanding of the disease, the following three explore new advancements and treatments, particularly looking at overcoming resistance to therapy, and the remaining three chapters focus on specific molecules with the potential to become drug targets. We all have much to learn about prostate cancer. This book is aimed primarily at clinicians and scientists, but many areas will also be of interest to the layperson.
Prostate --- Epidemiology of Prostate Cancer; Etiology of Prostate Cancer; Pathogenesis of Prostate Cancer; Current Diagnostics for Prostate Cancer; Combination Treatment for Prostate Cancer; Castration-Resistant Prostate Cancer; Theranostics in Metastatic Castrate Resistant Prostate Cancer; Adenocarcinoma of the Prostate; p53 in Prostate Cancer; MUCIN 1 in Prostate Cancer; STEAP Proteins in Prostate Cancer --- Cancer. --- Epidemiology of Prostate Cancer; Etiology of Prostate Cancer; Pathogenesis of Prostate Cancer; Current Diagnostics for Prostate Cancer; Combination Treatment for Prostate Cancer; Castration-Resistant Prostate Cancer; Theranostics in Metastatic Castrate Resistant Prostate Cancer; Adenocarcinoma of the Prostate; p53 in Prostate Cancer; MUCIN 1 in Prostate Cancer; STEAP Proteins in Prostate Cancer
Choose an application
The theory of a stem-cell origin of cancer is neither ground breaking nor earth shattering. Many prominent investigators have established the foundation for this concept and performed the vital experiments to support its validity and merit. The purpose of this book is to illustrate how this theory may completely transform our current views and perspectives about cancer. It is anticipated that the variety of ramifications of a stem-cell origin of cancers will be embraced by the medical research community to bring new treatment modalities to the cancer patient. "The stem-cell theory of cancer has significant biologic and clinical consequences. Though components remain open to debate the fundamental observations are grounded in scientific experimentation. This text explains the conceptual aspects of cancer stem cells with an emphasis on the implications for our patients." - Steven T. Rosen, M.D. Series Editor .
Cancer -- Epidemiology. --- Cancer -- Etiology. --- Cancer -- Prevention. --- Cancer --- Stem cells --- Neoplasms --- Diseases --- Oncology --- Medicine --- Health & Biological Sciences --- Etiology --- Stem cells. --- Etiology. --- Colony-forming units (Cells) --- Mother cells --- Progenitor cells --- Medicine. --- Cancer research. --- Human genetics. --- Oncology. --- Medicine & Public Health. --- Cancer Research. --- Human Genetics. --- Cells
Choose an application
Prostate cancer is a life-altering diagnosis, not just for patients, but for their loved ones as well. Once, prostate cancer was most frequently diagnosed in men in their 60s and 70s; with increasing use of imaging modalities and PSA testing, the incidence is on the rise, and we are now seeing men in their 40s with the disease. This poses a challenge for clinical management depending on the stage of the disease—from watchful waiting or active surveillance to aggressive treatment with the risk of therapeutic nihilism. Despite being one of the most common cancers in Western men, its natural history, prognosis, and treatment are poorly understood. This book brings together a select faculty of experts to present a comprehensive view of the current state and future perspectives of prostate cancer. There are ten chapters in the book—the first four cover our present knowledge and understanding of the disease, the following three explore new advancements and treatments, particularly looking at overcoming resistance to therapy, and the remaining three chapters focus on specific molecules with the potential to become drug targets. We all have much to learn about prostate cancer. This book is aimed primarily at clinicians and scientists, but many areas will also be of interest to the layperson.
Prostate --- Cancer. --- Epidemiology of Prostate Cancer; Etiology of Prostate Cancer; Pathogenesis of Prostate Cancer; Current Diagnostics for Prostate Cancer; Combination Treatment for Prostate Cancer; Castration-Resistant Prostate Cancer; Theranostics in Metastatic Castrate Resistant Prostate Cancer; Adenocarcinoma of the Prostate; p53 in Prostate Cancer; MUCIN 1 in Prostate Cancer; STEAP Proteins in Prostate Cancer
Choose an application
Prostate cancer is a life-altering diagnosis, not just for patients, but for their loved ones as well. Once, prostate cancer was most frequently diagnosed in men in their 60s and 70s; with increasing use of imaging modalities and PSA testing, the incidence is on the rise, and we are now seeing men in their 40s with the disease. This poses a challenge for clinical management depending on the stage of the disease—from watchful waiting or active surveillance to aggressive treatment with the risk of therapeutic nihilism. Despite being one of the most common cancers in Western men, its natural history, prognosis, and treatment are poorly understood. This book brings together a select faculty of experts to present a comprehensive view of the current state and future perspectives of prostate cancer. There are ten chapters in the book—the first four cover our present knowledge and understanding of the disease, the following three explore new advancements and treatments, particularly looking at overcoming resistance to therapy, and the remaining three chapters focus on specific molecules with the potential to become drug targets. We all have much to learn about prostate cancer. This book is aimed primarily at clinicians and scientists, but many areas will also be of interest to the layperson.
Prostate --- Cancer. --- Epidemiology of Prostate Cancer; Etiology of Prostate Cancer; Pathogenesis of Prostate Cancer; Current Diagnostics for Prostate Cancer; Combination Treatment for Prostate Cancer; Castration-Resistant Prostate Cancer; Theranostics in Metastatic Castrate Resistant Prostate Cancer; Adenocarcinoma of the Prostate; p53 in Prostate Cancer; MUCIN 1 in Prostate Cancer; STEAP Proteins in Prostate Cancer
Choose an application
Molecular Therapies of Cancer comprehensively covers the molecular mechanisms of anti-cancer drug actions in a comparably systematic fashion. While there is currently available a great deal of literature on anti-cancer drugs, books on the subject are often concoctions of invited review articles superficially connected to one another. There is a lack of comprehensive and systematic text on the topic of molecular therapies in cancer. A further deficit in the relevant literature is a progressive sub-specialization that typically limits textbooks on cancer drugs to cover either pharmacology or medicinal chemistry or signal transduction, rather than explaining molecular drug actions across all those areas; Molecular Therapies of Cancer fills this void. The book is divided into five sections: 1. Molecular Targeting of Cancer Cells; 2. Emerging and Alternative Treatment Modalities; 3. Molecular Targeting of Tumor-Host Interactions; 4. Anti-Cancer Drug Pharmacokinetics; and 5. Supportive Therapies.
Biomedicine. --- Cancer Research. --- Laboratory Medicine. --- Oncology. --- Medicine. --- Medical laboratories. --- Médecine --- Cancérologie --- Cancer -- Chemotherapy. --- Cancer -- Etiology. --- Cancer -- Genetic aspects. --- Cancer -- Molecular aspects. --- Molecular biology. --- Medicine --- Health & Biological Sciences --- Oncology --- Cancer --- Chemotherapy. --- Molecular aspects. --- Etiology. --- Genetic aspects. --- Cancer genetics --- Molecular biochemistry --- Molecular biophysics --- Cancer research. --- Laboratory medicine. --- Biochemistry --- Biophysics --- Biomolecules --- Systems biology --- Cancer genes --- Antineoplastic agents --- Treatment --- Oncology . --- Tumors --- Diagnosis, Laboratory --- Health facilities --- Laboratories --- Clinical medicine --- Clinical pathology --- Diagnostic laboratory tests --- Laboratory diagnosis --- Laboratory medicine --- Medical laboratory diagnosis --- Diagnosis --- Pathology --- Cancer research
Choose an application
Cancer is a major cause of human morbidity and mortality worldwide. Despite decades of basic and clinical research, the outcome for many cancer patients is still dismal. Although the existence of "stem-like" cells in cancer was hypothesized more than 150 years ago, recent discoveries have the potential to revolutionize cancer therapy. In particular, we now know that many cancers contain a fraction of self-renewing, drug- and radiation-resistant cells (cancer stem cells or cancer-initiating cells) and it is these cells—and not the major bulk of the tissue—that are the root cause for cancer initiation, relapse and metastasis. In a single volume, Stem Cells and Cancer offers up-to-date information about the role of stem cells in the development of normal and cancerous tissue, the mechanisms that differentiate normal from cancerous functions, and the use of these findings in developing mechanism-based therapies across all major types of cancer. It provides timely, cutting-edge information about cancer stem cells from the perspectives of both the basic and clinical sciences.
Cancer cells. --- Cancer --Etiology. --- Cancer --Treatment. --- Carcinogenesis. --- Cytology. --- Medicine. --- Oncology. --- Stem cells. --- Cancer cells --- Carcinogenesis --- Cancer --- Stem cells --- Cell Transformation, Neoplastic --- Stem Cells --- Neoplastic Stem Cells --- Neoplasms --- Diseases --- Neoplastic Processes --- Cells --- Pathologic Processes --- Anatomy --- Pathological Conditions, Signs and Symptoms --- Oncology --- Medicine --- Health & Biological Sciences --- Etiology --- Treatment --- Etiology. --- Treatment. --- Cancer therapy --- Cancer treatment --- Colony-forming units (Cells) --- Mother cells --- Progenitor cells --- Therapy --- Cancer research. --- Cell biology. --- Biomedicine. --- Cancer Research. --- Cell Biology. --- Pathology, Cellular --- Oncology . --- Tumors --- Cell biology --- Cellular biology --- Biology --- Cytologists --- Cancer research
Choose an application
Breast Cancer is the most common tumor in women and it is the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of the mammary gland had greatly increased over the last decade. In Breast Cancer in the Post Genomic Era, Antonio Giordano, Nicola Normanno, and a panel of international authorities in their field provide a comprehensive approach to the biology, diagnosis, prevention, and treatment of human breast carcinoma. The book provides a comprehensive approach to breast cancer, describing the use of gene profiling techniques to distinguish specific features of individual carcinomas, as well as emerging novel therapeutic approaches to treatment. Additional chapters cover the use of transgenic mice to model human breast cancer and the role of the EGF-CFC family in mammary gland development and neoplasia. Breast Cancer in the Post Genomic-Era succeeds in looking at breast cancer pathogenesis, diagnosis, and treatment under a more comprehensive light, and is a valuable resource for any Radiation or Surgical Oncologist, Cancer Biologist or Pathologist.
Breast -- Cancer -- Diagnosis. --- Breast -- Cancer -- Etiology. --- Breast -- Cancer -- Genetic aspects. --- Breast -- Cancer -- Treatment. --- Breast --- Breast Diseases --- Neoplasms by Site --- Neoplasms --- Skin Diseases --- Skin and Connective Tissue Diseases --- Diseases --- Breast Neoplasms --- Medicine --- Health & Biological Sciences --- Oncology --- Cancer --- Etiology --- Diagnosis --- Treatment --- Genetic aspects --- Diagnosis. --- Etiology. --- Genetic aspects. --- Treatment. --- Medicine. --- Oncology. --- Pathology. --- Surgical oncology. --- Medicine & Public Health. --- Surgical Oncology. --- Oncology . --- Disease (Pathology) --- Medical sciences --- Medicine, Preventive --- Oncologic surgery --- Oncological surgery --- Surgical oncology --- Tumors --- Excision
Choose an application
Cervix uteri -- Cancer -- Etiology. --- Cervix uteri -- Cancer -- Prevention. --- Cervix uteri -- Cancer -- Treatment. --- Precancerous Conditions --- Uterine Cervical Neoplasms --- Cervical Intraepithelial Neoplasia --- Uterine Cervical Diseases --- Carcinoma in Situ --- Uterine Neoplasms --- Neoplasms --- Uterine Diseases --- Genital Neoplasms, Female --- Diseases --- Carcinoma --- Genital Diseases, Female --- Urogenital Neoplasms --- Neoplasms, Glandular and Epithelial --- Female Urogenital Diseases --- Neoplasms by Histologic Type --- Neoplasms by Site --- Female Urogenital Diseases and Pregnancy Complications --- Cervix uteri --- Precancerous conditions --- Diagnosis.
Listing 1 - 10 of 15 | << page >> |
Sort by
|